Theratechnologies Inc T.TH

The Ball is in THTX's Court

[longterm56]

The waiting for other people and/or institutions is now over ... and what happens from here on is solely in the Thera's court.  We are no longer waiting on the NASH experts, the FDA, test results from NIH, papers being published ....  it is now all on Thera.

Some say we are waiting on the analysts to get it right, but they have spoken. They might be lazy or ignorant of the details of what Thera has, but that doesn't matter ...  the reason their reports are not supportive is because THEY ARE UNCONVINCED ... and the responsibility for changing that is solely on Thera. 

So ... Paul ... no pressure ... lol.

   -LT

[scarlet1967]

I absolutely share that opinion the remarkable achievements to get NASH phase 3 soon to end line as per agencies approval of the protocol, starting the oncology platform in timely manner and increasing sales in the middle of pandemic when others have failed can't go unrecognized by the market so now they need to market it hard and effectively. Attending as many conferences, using social media

[Lee430]

Really with such great news from Thera I was hoping/expecting to end the week over $5, then next week we could see if there really is some pent-up institutional demand that could start to drive us back into double digits again…. My wife constantly reminds me to take baby steps soooo happy to celebrate $3 as a first step.

[scarlet1967]

$5 Canadian or more also open up access to more funds for Canadian margin account holders, I have heard people talking about potential offering which could be a reason for not better reaction to solid good news anyway I believe in the next few months when company attend conferences they present their case in a convincing matter for instance the NASH protocol being innovative should come across as

[muslix1]

I think that whit the good news of last week, we are becoming an intersting target for a potential offering for a company like Pfizer where Paul worked 25 years otherwise Merck where Dawn worked 23 years... These compagnies have time and money.

[FredTheVoice]

Muslix, I am not saying you are wrong, but think about that........ After more than two years of negative vibe, even if the news were relatively good, we are now back (because we all were wrong about the turning point.......because its NOW), we are back in the POSITIVE ERA, POSITIVE CIRCLE or wathever you want to call it...........news will be climbing one after the other, investors will jump in,

[realitycheck4u]

This post has been removed in accordance with Community Policy

[Jasonthehumble]

Agreed with all of the investors on this board. We have been waiting way to long for results of NASH and even waited longer with the sales of the 2 current TROGARZO AND EFITGIA.  We dont not want a buyout or an aquistion of bigger pharma. Please reward your shareholders for their patience and not give it to big pharma when we are just starting to snowball down the hill.

[SPCEO1]

I would not sweat the risk of a way too early big pharma buyout too much. I don't think a rather young Paul is ready to hang up his cleats just yet. And even if he was, I suspect we may all own enough of the shares to block and unwanted takeover if we desired to do so. However, that will likely not be necessary as our board does not seem to me like the type that would sell out too cheaply or

[muslix1]

Yes you are right Fred ... But this time , there are too many things for THERA to go unnoticed ... And after 11 years of waiting i'm not at 2 years to have 10 times my money...

[SPCEO1]

And it really should not be hard at this point to convince the analysts as the phase III is real. It may take the a while for them to get their head around the fact that THTX is a phase III NASH stock, but since this is now undeniable, they will eventually come around. RBC offered lame excuses for not fully acknowledging the reality of the situation, but the analyst is smart enough to know his

[scarlet1967]

THTX is not the only biotech with promising prospects they are hundreds of small companies out there, again if we look at how they market themselves the ones who are proactively reaching out to investors are valued much more than the rest. For instance as mentioned earlier some have a section re partnership in their website and often they already have teamed up with bigger pharmas, it is a very

[scarlet1967]

I am looking forward to when company is ahead of us and analysts meaning they know how to handle both the analysts and the whole market.